Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study

Open Access

Peer-reviewed

Research Article

Ruth Brauer ,

* E-mail: Ruth.brauer@lshtm.ac.uk

Affiliation Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom
⨯
Krishnan Bhaskaran,

Affiliation Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom
⨯
Nishi Chaturvedi,

Affiliation Institute of Cardiovascular Sciences, University College London, London, United Kingdom
⨯
David T. Dexter,

Affiliation Centre for Neuroinflammation & Neurodegeneration, Division of Brain Sciences, Faculty of Medicine, Imperial College, London, United Kingdom
⨯
Liam Smeeth,

Affiliation Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom
⨯
Ian Douglas

Affiliation Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom
⨯

Reader Comments (3)

Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Parkinson disease
Is the Subject Area "Parkinson disease" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Epidemiology
Is the Subject Area "Epidemiology" applicable to this article?

Thanks for your feedback.
Primary care
Is the Subject Area "Primary care" applicable to this article?

Thanks for your feedback.
Cohort studies
Is the Subject Area "Cohort studies" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Neuroprotectives
Is the Subject Area "Neuroprotectives" applicable to this article?

Thanks for your feedback.